文传商讯
Galderma @ EADV 2023: Phase III Trials Demonstrate Nemolizumab’s Efficacy and Rapid Onset of Action
2023-10-12 19:00:08
SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers
2023-10-12 19:00:08
Evobrutinib, CNS-Penetrant BTKi, Has Shown Sustained Clinical Benefit Up to Five Years in People wit
2023-10-12 19:00:08
Merck Presents New MAVENCLAD (Cladribine Tablets) Data Highlighting Sustained Reduction in NfLs and
2023-10-12 19:00:08
